New lessons for an old problem: ASSET open-label extension

被引：0
|
作者：
Del Galdo, Francesco [1 ,2 ]
机构：
[1] Univ Leeds, Inst Rheumat & Musculoskeletal Med, Scleroderma Programme, Leeds LS7 4SA, W Yorkshire, England
[2] Natl Inst Hlth, Res Biomed Res Ctr, Leeds, W Yorkshire, England
来源：
LANCET RHEUMATOLOGY | 2020年 / 2卷 / 12期
关键词：
ABATACEPT; EFFICACY; SAFETY; CTLA4;
D O I：
10.1016/S2665-9913(20)30379-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：E726 / E727
页数：2
相关论文
共 50 条
  • [41] An Open-Label Extension Trial Of Oral Treprostinil In Subjects With Pulmonary Arterial Hypertension
    White, R. J.
    Jing, Z. -C.
    Parikh, K.
    Bartolome, S.
    Allen, R. P.
    Xu, K. -F.
    Shapiro, S.
    Feldman, J.
    Crawford, K.
    Arneson, C.
    Laliberte, K.
    Tapson, V. F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [42] Safety and Tolerability of Donepezil in Mild Cognitive Impairment: Open-Label Extension Study
    Doody, Rachelle S.
    Ferris, Steven
    Salloway, Stephen
    Sun, Yijun
    Goldman, Robert
    Xu, Yikang
    Gao, Jeff
    Murthy, Anita K.
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2010, 25 (02): : 155 - 159
  • [43] A SIX-MONTH OPEN-LABEL EXTENSION STUDY OF VORTIOXETINE IN PEDIATRIC PATIENTS
    Findling, Robert L.
    Robb, Adelaide S.
    DelBello, Melissa P.
    Huss, Michael
    McNamara, Nora K.
    Sarkis, Elias H.
    Scheffer, Russell E.
    Poulsen, Lis H.
    Chen, Grace
    Lemming, Ole M.
    Auby, Philippe
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S183 - S183
  • [44] Durability of recaptured response to ozanimod during the True North open-label extension
    Dignass, A.
    Regueiro, M.
    Colombel, J. F.
    Jain, A.
    Canavan, J. B.
    Wu, H.
    Lawlor, G.
    Osterman, M. T.
    Vermeire, S.
    Rubin, D. T.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 817 - 818
  • [45] Open-Label Extension Study of Flibanserin in Women with Hypoactive Sexual Desire Disorder
    Jayne, Christopher
    Simon, James A.
    Taylor, Leslie V.
    Kimura, Toshio
    Lesko, Lynna M.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 (12): : 3180 - 3188
  • [46] Safety and Efficacy of Epratuzumab in an Open-Label Extension Study (SL0006)
    Hobbs, K.
    Wallace, D. J.
    Strand, V.
    Kalunian, K.
    Kilgallen, B.
    Bongardt, S.
    Wegener, W. A.
    Goldenberg, D. M.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S276 - S277
  • [47] Aripiprazole versus olanzapine in a 52-week, open-label extension study
    McQuade, R
    Kostic, D
    Marcus, R
    Carson, W
    Torbeyns, A
    Kerselaers, W
    Yocca, F
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 496 - 497
  • [48] Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension
    Pittock, Sean J.
    Fujihara, Kazuo
    Palace, Jacqueline
    Berthele, Achim
    Kim, Ho Jin
    Oreja-Guevara, Celia
    Nakashima, Ichiro
    Levy, Michael
    Shang, Shulian
    Yountz, Marcus
    Miller, Larisa
    Armstrong, Roisin
    Wingerchuk, Dean M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (03) : 480 - 486
  • [49] SARILUMAB DOSE REDUCTION IN AN OPEN-LABEL EXTENSION STUDY IN RHEUMATOID ARTHRITIS PATIENTS
    Genovese, Mark C.
    Fay, Jon
    Parrino, Janie
    Beyer, Doris
    Iglesias-Rodriguez, Melitza
    Graham, Neil
    Boddy, Alex
    Martincova, Renata
    Burmester, Gerd R.
    RHEUMATOLOGY, 2017, 56 : 139 - 139
  • [50] Preliminary Results of the OPERA I and OPERA II Open-Label Extension Study
    Naismith, Robert
    Cascione, Mark
    Grimaldi, Luigi Maria
    Hauser, Stephen
    Kappos, Ludwig
    Montalban, Xavier
    Wolinsky, Jerry
    Chin, Peter
    Garren, Hideki
    Julian, Laura
    Model, Fabian
    Honeycutt, David
    NEUROLOGY, 2017, 88
12345